Inventor · disambiguated record
Brian H. White
Also filed as: WHITE BRIAN · WHITE BRIAN H · WHITE BRIAN HALBERT
12 granted patents·19 pending applications·44 citations·filing 2009–2025
89Inventor score
Files withTARVEDA THERAPEUTICS INC15GLAXOSMITHKLINE LLC4FOG PHARMACEUTICALS INC3BLEND THERAPEUTICS INC2GENOV DANIEL G2
Top patents by PatentIndex Score
31 records- 0192US9394313B2Transfer hydrogenation of cyclopamine analogsGENOV DANIEL G·Filed 2011·Granted Jul 19, 2016·12 cites·24 claims
- 0292US9376447B2Transfer hydrogenation of cyclopamine analogsGENOV DANIEL G·Filed 2011·Granted Jun 28, 2016·12 cites·19 claims
- 0390US9879025B2Transfer hydrogenation of cyclopamine analogsINFINITY PHARMACEUTICALS INC·Filed 2016·Granted Jan 30, 2018·3 cites·13 claims
- 0487US9750818B2Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2016·Granted Sep 5, 2017·6 cites·2 claims
- 0586US10624967B2Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Apr 21, 2020·2 cites·8 claims
- 0684US9765075B2Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2014·Granted Sep 19, 2017·2 cites·4 claims
- 0782US10322191B2Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Jun 18, 2019·3 cites·5 claims
- 0879US11241500B2HSP90-targeting conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Granted Feb 8, 2022·1 cites·19 claims
- 0976US9834558B2Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2014·Granted Dec 5, 2017·2 cites·2 claims
- 1076US2020121808A1Sstr-targeted conjugates encapsulated in particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1173US2022288229A1Targeted conjugates encapsulated in particles and formulations thereofTVA ABC LLC·Filed 2022·Application pending·0 cites
- 1272US9326986B2Quinazolinone, quinolone and related analogs as sirtuin modulatorsVU CHI B·Filed 2009·Granted May 3, 2016·1 cites·16 claims
- 1365US2018044338A1Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2017·Application pending·0 cites
- 1464US11458206B2Targeted conjugates and particles and formulations thereofTVA ABC LLC·Filed 2020·Granted Oct 4, 2022·0 cites·6 claims
- 1564US2022096640A1Hsp90-targeting conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1662US10590135B2Substituted bridged urea analogs as sirtuin modulatorsGLAXOSMITHKLINE LLC·Filed 2015·Granted Mar 17, 2020·0 cites·11 claims
- 1760US2014187501A1Targeted Conjugates Encapsulated in Particles and Formulations ThereofBLEND THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 1859US2018021454A1Targeted conjugates encapsulated in particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1958US2025387492A1Hsp90-targeting conjugates and formulations thereofFUSION PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2055US2024360179A1Stapled peptides and methods thereofFOG PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 2154US2016074526A1Sstr-targeted conjugates encapsulated in particles and formulations thereofBLEND THERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 2254US2023271917A1Amino acidsFOG PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2353US2024116985A1Stapled peptides and methods thereofFOG PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2452US2021145971A1Hsp90-targeting conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2551US2022184217A1Hsp90-binding conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2649US2022031853A1Hsp90-targeting conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2745US2020009262A1Targeted constructs and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2843US2020078468A1Neurotensin receptor binding conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2941US2021000966A1Hsp90-targeting conjugates and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3041US2019125888A1Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 3138US2017151339A1Targeted conjugates and particles and formulations thereofTARVEDA THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brian H. White files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →